• Home
  • SPECIALITY
    • General Medicine
    • Cardiology
    • Critical Care Medicine
    • Dermatology
    • Dentistry
    • Diabetology
    • ENT
    • Gastroenterology & Hepatology
    • HIV / AIDS
    • Infectious Diseases
    • Musculoskeletal Diseases
    • Neuropsychiatry
    • Obstetrics & Gynecology
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Respiratory Medicine
    • Surgery
    • Urology
  • TOPICS
    Currently there are no topics under this speciality
  • SCIENTIFIC RESOURCES
  • Product Index
  • Infographics
Logo
Filter

 

Search form

Get Ciplamed App

google play ios
Login
Register
Menu
  • New Content
  • Medical News
  • eCMEs
  • Scientific Resources
    • Expert's Views
    • Our Publications
    • Slide Library
    • Guidelines
    • Our Research
    • Key Trials
    • Conference Proceedings
    • Patient Education
    • Clinical Tools
    • Device Demos
    • Journals
    • Useful Links
    • Expert's Views
    • Our Publications
    • Slide Library
    • Guidelines
    • Our Research
    • Key Trials
    • Conference Proceedings
    • Patient Education
    • Clinical Tools
    • Device Demos
    • Journals
    • Useful Links
  • Topics
    • Acne
    • Addiction
    • Adolescent Health
    • Aging Skin
    • Allergic Rhinitis
    • Allergy
    • Allied
    • Allied Interventions in HIV/AIDS
    • Analgesia in the ICU
    • Anti-infectives
    • Antibacterials
    • Antiretroviral Management in Adults and Adolescents
    • Antiretroviral Management in Pediatrics
    • Anxiety & Depression
    • Arrhythmia
    • Asthma
    • Atrial Fibrillation
    • BPH
    • Bacterial Infections
    • Benign Prostatic Hyperplasia
    • Bipolar Disorder
    • Bladder Dysfunction
    • Brain Cancer
    • Breast Cancer
    • CNS
    • COPD
    • Cardiology
    • Cardiovascular Disorder
    • Chronic Kidney Disease
    • Colorectal Cancer
    • Congenital Heart Disease
    • Contraception
    • Dementia
    • Dengue
    • Dermatological Disorder
    • Diabetes
    • Drug - Drug Interactions
    • Gastrointestinal Disorder
    • Dry Eye
    • Dyslipidemia
    • ENT Infections
    • Ebola Virus Disease
    • EpidemiologyEpidemiology
    • Epilepsy
    • Fungal Infections
    • Gallbladder & Biliary Tract
    • Gastroenterological Tract
    • Gastroenterology and Nutrition
    • Gastrointestinal Cancers
    • General
    • Genito-Urinary Disorders
    • Glaucoma
    • Gout
    • Gynecological Cancers
    • HIV / AIDS
    • HIV Resistance
    • HIV Testing
    • HIV and Aging
    • HIV prevention aproaches
    • Haematological Malignancies
    • Hair Care
    • Hair and Scalp Disease
    • Headache
    • Heart Failure
    • Heart Failure and Cardiomyopathy
    • Hematology
    • Hepatitis
    • Herpes
    • Hyperpigmentation
    • Hypertension
    • IHD
    • IPF
    • Infection Control and Prevention
    • Infection Prevention & Control
    • Infections
    • Infertility
    • Inflammation / Infection
    • Influenza
    • Ischemic Heart Disease
    • Kidney & Urinary Tract
    • Laryngology
    • Liver
    • Lower GI Tract
    • Lung Cancer
    • MRSA
    • Malaria
    • Malaria
    • Management of HIV in Key Populations
    • Management of Non-infectious Comorbidities in HIV
    • Medical Abortion
    • Menopause
    • Movement Disorder
    • Multiple Sclerosis
    • Neonatology
    • Neurology
    • Osteoporosis
    • PAH
    • Pancreas
    • Psoriasis
    • hearing loss
    • Tuberculosis
    • Rheumatic Disorders
    • Respiratory and Allergy
    • Renal Cancer
    • Acne
    • Addiction
    • Allergy
    • Anti-infectives
    • BPH
    • Cardiovascular Disorder
    • Dermatological Disorder
    • Diabetes
    • Dyslipidemia
    • Ebola Virus Disease
    • Gastrointestinal Disorder
    • Headache
    • Hepatitis
    • Hypertension
    • Infection Prevention & Control
    • Infections
    • Influenza
    • Inhalation Devices
    • Kidney & Urinary Tract
    • Malaria
    • Medico-Legal
    • Musculoskeletal Disorder
    • Neurological Disorder
    • Respiratory Tract Disorder
  • Infographics
  • Product Index
  • Medico-Legal

You are here

Home»Array»Topics

Topics

  • Allied Interventions in HIV/AIDS
  • Antiretroviral Management in Adults and Adolescents
  • Antiretroviral Management in Pediatrics
  • Epidemiology
  • HIV Resistance
  • HIV Testing
  • HIV and Aging
  • Management of HIV in Key Populations
  • Management of Non-infectious Comorbidities in HIV
  • Opportunistic Infections and Coinfections
  • Post-exposure prophylaxis (PEP)
  • Pre-exposure Prophylaxis (PrEP)
  • Preventing Mother to Child Transmission
  • Primary Care in HIV
  • Treatment as Prevention (TasP)

Guidelines

  • WHO: Update of Recommendations on First- And Second-Line Antiretroviral Regimens (2019)
  • WHO: Consolidated Strategic Information Guidelines for HIV in the Health Sector
  • BHIVA: Guidelines on the Use of Vaccines in HIV-positive Adults 2015
  • WHO: Guideline on the Use of Devices for Adult Male Circumcision for HIV Prevention (2013)

Webcasts

  • Success After Failure: Moving beyond First-line Therapy
  • IAS 2015: A Game Changer
  • Sustaining Success in Treatment-Experienced Patients

Our Publications

  • Antiretroviral Therapy – Current Recommendations
  • Defining Treatment Failure
  • Managing First-Line Failure

Slide Library

  • WHO 2016 - Clinical Guidelines: Antiretroviral Therapy

Key Trials

  • 144-week Efficacy and Safety of Fixed-dose Combination Bictegravir, Emtricitabine, and Tenofovir alafenamide versus Dolutegravir-containing Regimens for Initial Treatment of HIV-1 Infection
  • Long Acting Injectables (CAB+RPV) for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase III ATLAS and FLAIR Studies
  • ADVANCE Trial: 96-week Efficacy and Safety of DTG Combined with FTC and TAF or TDF versus EFV Combined with FTC and TDF
  • PRADAR Study: Virological Efficacy of Abacavir/Lamivudine + DRV/r vs Abacavir/ Lamivudine + RAL in Treatment -naïve HIV Patients with CD4<200 cells/μL
  • Switching to FTC/TAF from FTC/TDF in Virologically Suppressed Patients receiving a Boosted PI or an Unboosted Third Agent
  • ADVANCE Trial: DTG Combined with TAF or TDF, Noninferior to the Standard -of- care Regimen at Week 48
  • TAF Based Regimen Superior to TDF–based Regimen in Efficacy and Renal and Bone Safety for Initial HIV-1 Treatment
  • Safety and Efficacy of E/C/F/TAF vs E/C/F/TDF in Treatment Naïve HIV Patients
    • Single-Tablet Regimen Containing RPV/FTC/TDF in Virologically Suppressed HIV-1 Patients Improves Cholesterol and Triglycerides

Guidelines

  • WHO: Update of Recommendations on First- And Second-Line Antiretroviral Regimens (2019)
  • WHO: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection 2016- Recommendations for a Public Health Approach: second edition (2016)
  • European AIDS Clinical Society (EACS): Guidelines for Treatment of HIV-infected Adults in Europe (2016)
  • Southern African HIV Clinicians Society: Adult Antiretroviral Therapy Guidelines: Update on when to initiate antiretroviral therapy (2015)
  • BHIVA: Guidelines for the Treatment of HIV-1-positive Adults with Antiretroviral Therapy (2015)
  • Southern African HIV Clinicians Society: Guideline on Adult Antiretroviral Therapy Guidelines 2014

Our Publications

  • Datasheet: Lopinavir and Ritonavir (40mg/10mg) Oral Pellets
  • Fast Facts: Lopinavir and Ritonavir (40 mg/10 mg) Oral Pellets
  • HMS: Paediatric HIV/AIDS - A Clinician’s Guide

Clinical Tools

  • BSA Calculator

Guidelines

  • DHHS: Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (2020)
  • WHO: Updated Recommendations On First-line and Second-line Antiretroviral Regimens and Post-exposure Prophylaxis and Recommendations on Early Infant Diagnosis of HIV: Interim Guidance (2018)
  • WHO: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection 2016- Recommendations for a Public Health Approach: second edition (2016)
  • DHHS: Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (2016)
  • PENTA: Paediatric European Network for Treatment of AIDS (PENTA) Guidelines for Treatment of Paediatric HIV-1 Infection: Optimizing Health in Preparation for Adult Life (2015)

Guidelines

  • WHO: Data and Statistics (2016)
  • UNAIDS: Global AIDS Epidemic (2016)
  • WHO: Guidelines on Monitoring the Impact of the HIV Epidemic Using Population-based Surveys (2015)

Webcasts

  • Success After Failure: Moving beyond First-line Therapy

Guidelines

  • WHO: Global Report on Early Warning Indicators of HIV Drug Resistance (2016)

Guidelines

  • WHO: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection 2016- Recommendations for a Public Health Approach: second edition (2016)
  • WHO: Consolidated Guidelines on HIV Testing Services (2015)

Guidelines

  • UNAIDS: HIV and Aging: A Special Supplement (2013)

Guidelines

  • WHO: Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations (2016)

Our Publications

  • ERA Series 6: Neuropsychiatry
  • ERA Series 5: Hepatic
  • ERA Series 4: Renal
  • ERA Series 3: Metabolic
  • ERA Series 2: Cardiovascular
  • ERA Series 1: Screening
  • IRIS: A Clinical Challenge
  • Managing First-Line Failure

Clinical Tools

  • Algorithm for Management of Osteopenia/Osteoporosis in HIV-Infected Patients
  • eGFR Calculator
  • Cockgroft Gault Equation
  • MDRD GFR Calculator
  • 10 year Risk for Coronary Heart Disease Framingham Point Scores
  • 10-year Risk of Developing CHD (Myocardial Infarction and Coronary Death)
  • Fracture Risk Assessment Tool
  • 10 year Fracture Risk Calculator

Guidelines

  • WHO: Integrating Collaborative TB and HIV Services Within a Comprehensive Package of Care for People who Inject Drugs (2016)
  • Guideline on Management of Mental Health Disorders and Central Nervous System Sequelae in HIV-positive Children and Adolescents (2014)
  • BHIVA: Guidelines for HIV-associated Malignancies (2014)
  • Southern African HIV Clinicians Society: Guideline on Management of Mental Health Disorders in HIV-positive Patients (2014)
  • Southern African HIV Clinicians Society: Guideline on Consensus statement: Management of Drug-induced Liver Injury in HIV-positive Patients Treated for TB (2013)

Webcasts

  • Role of Prophylactic Therapy in Advanced HIV disease

Our Publications

  • Isoniazid + Pyridoxine + Sulfamethoxazole + Trimethoprim - Fixed Dose Combination: Concept Document
  • Opportunistic Infections: Factsheet
  • Nutshell Series 6: Human Papilloma Virus Disease
  • Nutshell Series 1: Pneumocystis carinii pneumonia (PCP)
  • Nutshell Series 2: Tuberculosis Infection and Disease

Slide Library

  • HIV - HCV Coinfection
  • Isoniazid Preventive Therapy in HIV Infection

Key Trials

  • REALITY: Enhanced Antimicrobial Prophylaxis + ART Improves Survival in Advanced HIV Patients
    • PHOTON 2: Interferon-Free Regimen of Sofosbuvir Plus Ribavirin Highly Effective for the Treatment of HIV Patients Co-infected with HCV

Guidelines

  • DHHS: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (2020)
  • Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-infected Adults, Adolescents and Children (2018)
  • DHHS: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (2017)
  • CDC: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (2016)
  • DHHS: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children (2016)
  • BHIVA: Guidelines for the Management of Hepatitis Viruses in Adults Infected with HIV (2013)

Our Publications

  • HMS: Antiretroviral-based Prevention Strategies in HIV

Slide Library

  • HIV- Post-exposure Prophylaxis (PEP)

Guidelines

  • Southern African HIV Clinicians Society: Guideline on the Management of Occupational and Non-Occupational Exposure to the Human Immunodeficiency Virus and recommendations for post-exposure prophylaxis: 2015 Update (2016)
  • WHO: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection 2016- Recommendations for a Public Health Approach: second edition (2016)
  • BHIVA:UK National Guideline for the Use of HIV Post-Exposure Prophylaxis Following Sexual Exposure (PEPSE) 2015
  • CDC: Recommendations for HIV Prevention with Adults and Adolescents with HIV in the United States (2014)
  • WHO: Guidelines on Post-exposure Prophylaxis for HIV and the Use of Co-trimoxazole Prophylaxis for HIV-related Infections among Adults, Adolescents and Children (2014)
  • CDC: U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Post-exposure (2013)

Our Publications

  • Antiretroviral-based Prevention Strategies in HIV
  • HMS: Antiretroviral-based Prevention Strategies in HIV

Slide Library

  • HIV - Pre-exposure Prophylaxis (PrEP): Guidance on PrEP Use
  • HIV - Pre-exposure Prophylaxis (PrEP): Key Clinical Trials
  • HIV - Pre-exposure Prophylaxis (PrEP): Introduction to PrEP

Key Trials

  • DISCOVER Study: Efficacy and Safety of F/TAF with F/TDF for the Prevention of HIV Among Cisgender MSM and Transgender Women Who Have Sex with Men
  • Pre-exposure Chemoprophylaxis with Oral FTC–TDF Prevents HIV Acquisition in Men Who have Sex with Men
  • Partners PrEP Study: Oral TDF or TDF–FTC Significantly Reduces the Risk of HIV-1 Acquisition among Heterosexual Men and Women in Serodiscordant Relationships

Guidelines

  • WHO: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection 2016- Recommendations for a Public Health Approach: second edition (2016)
  • Southern African HIV Clinicians Society: Guidelines on the Safe Use of Pre-exposure Prophylaxis in Persons at Risk of Acquiring HIV-1 Infection (2016)
  • WHO: Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV (2015)
  • CDC: Pre-exposure Prophylaxis for the Prevention of HIV Infection – 2014 : A Clinical Practice Guideline (2014)

Our Publications

  • HMS: Antiretroviral-based Prevention Strategies in HIV
  • Preventing Mother to Child Transmission of HIV

Guidelines

  • BHIVA: Guidelines for the Management of HIV Infection in Pregnant Women (2012)

Guidelines

  • IDSA: Primary Care Guidelines for the Management of Persons Infected With HIV (2013)

Our Publications

  • HMS: Antiretroviral-based Prevention Strategies in HIV
  • New Content
  • Expert's Views
  • Guidelines
  • Clinical Tools
  • Device Demos
  • Product Index
  • PG Quiz
  • Journals
  • Useful Links
  • Calendar
  • Most Popular
  • CONTACT US
  • |
  • ABOUT US
  • |
  • SITEMAP
  • |
  • PRIVACY POLICY
  • |
  • DISCLAIMER

Connect with Us

Subscribe to Ciplamed Newsletter

  • WWW.CIPLA.COM
  • |
  • WWW.BREATHEFREE.COM
Get the App ios gplay
iosgplay
© Copyright 2021 -- All rights reserved  

Unsubscribe Whatsapp updates

Want to unsubscribe CiplaMed updates via Whatsapp?
Yes
x

Please enter the Unique ID (UID) given by Cipla Representative.